000 01134 a2200289 4500
005 20250516065354.0
264 0 _c20120822
008 201208s 0 0 eng d
022 _a1539-6924
024 7 _a10.1111/j.1539-6924.2011.01732.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIzadi, Hoda
245 0 0 _aEvaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings.
_h[electronic resource]
260 _bRisk analysis : an official publication of the Society for Risk Analysis
_cMay 2012
300 _a830-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBenchmarking
650 0 4 _aCanada
650 0 4 _aHumans
650 0 4 _aNo-Observed-Adverse-Effect Level
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Assessment
700 1 _aGrundy, Jean E
700 1 _aBose, Ranjan
773 0 _tRisk analysis : an official publication of the Society for Risk Analysis
_gvol. 32
_gno. 5
_gp. 830-5
856 4 0 _uhttps://doi.org/10.1111/j.1539-6924.2011.01732.x
_zAvailable from publisher's website
999 _c21352017
_d21352017